Thyroid Dysfunction and Heart Failure: Mechanisms and Associations

被引：16

作者：

Vargas-Uricoechea H. ^{[1
]}

Bonelo-Perdomo A. ^{[2
]}

机构：

[1] Division of Endocrinology and Metabolism, Internal Medicine Department, Universidad del Cauca, Carrera 6 No. 13N-50, Popayán, Cauca

[2] Division of Basic Immunology and Biomedical Sciences, Universidad del Valle-Campus San Fernando, Calle 4 B No. 36-00 Edificio 116 - Oficina 3001 (Tercer piso), Cali, Valle

来源：

Current Heart Failure Reports | 2017年 / 14卷 / 1期

关键词：

Heart failure; Hyperthyroidism; Hypothyroidism; Thyroid hormones;

D O I：

10.1007/s11897-017-0312-5

中图分类号：

学科分类号：

摘要：

Purpose of Review: The purpose of this review is to provide an update on the current knowledge of the pathophysiology, the mechanisms, and the cardiovascular impact of the different stages of thyroid dysfunction (TD) in heart failure (HF) patients. Recent Finding: The influence of thyroid hormones (THs) on the cardiovascular system involves the regulation of key processes related to maintenance of cardiac function; however, there are no long-term studies available showing that intervening the TD changes the incidence or the prognosis in HF individuals. Future research shall focus on the effects of cardiovascular morbidity and mortality associated with different treatment modalities for hyper and hypothyroidism. Summary: TD has been associated with different clinical results in HF individuals; treatment with THs in patients with hypothyroidism improves cardiovascular risk factors, but the effect on cardiovascular events has not been assessed in randomized, controlled trials. © 2017, Springer Science+Business Media New York.

引用

页码：48 / 58

页数：10

共 91 条

[1]

Buja A., Giuliana Solinas G., Visca M., Federico B., Gini R., Baldo V., Et al., Int J Environ Res Public Health, 13, (2016)

[2]

Levy D., Kenchaiah S., Larson M.G., Benjamin E.J., Kupka M.J., Ho K.K., Et al., Long-term trends in the incidence of and survival with heart failure, N Engl J Med, 347, pp. 1397-1402, (2002)

[3]

Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G., Coats A.J., Et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur J Heart Fail, 18, 8, pp. 891-975, (2016)

[4]

Deschaseaux C., McSharry M., Hudson E., Agrawal R., Turner S.J., Treatment initiation patterns, modifications, and medication adherence among newly diagnosed heart failure patients: a retrospective claims database analysis, J Manag Care Spec Pharm, 22, 5, pp. 561-571, (2016)

[5]

Jabbar A., Pingitore A., Pearce S.H., Zaman A., Iervasi G., Razvi S., Thyroid hormones and cardiovascular disease, Nat Rev Cardiol, 14, 1, pp. 39-55, (2017)

[6]

Taylor P.N., Razvi S., Pearce S.H., Dayan C.M., A review of the clinical consequences of variation in thyroid function within the reference range, J Clin Endocrinol Metab, 98, pp. 3562-3571, (2013)

[7]

Cappola A.R., Arnold A.M., Wulczyn K., Carlson M., Robbins J., Psaty B.M., Thyroid function in the euthyroid range and adverse outcomes in older adults, J Clin Endocrinol Metab, 100, pp. 1088-1096, (2015)

[8]

Wiersinga W.M., Guidance in subclinical hyperthyroidism and subclinical hypothyroidism: are we making progress?, Eur Thyroid J, 4, 3, pp. 143-148, (2015)

[9]

Taylor P.N., Iqbal A., Minassian C., Sayers A., Draman M.S., Greenwood R., Et al., Failing threshold for treatment of borderline elevated thyrotropin levels – balancing benefits and risks: evidence from a large community-based study, JAMA Intern Med, 174, pp. 32-39, (2014)

[10]

Klein I., Ojamaa K., Thyroid hormone and the cardiovascular system, New Eng J Med, 344, 7, pp. 501-509, (2001)

← 1 2 3 4 5 6 7 8 9 10 →